healthNewsغير مصنف

Biogen shares slip after Alzheimer’s data fails to convince

Biogen Inc and partner Eisai Co Ltd said on Thursday the highest dose of its experimental Alzheimer’s drug showed effectiveness in a new analysis, but investors remained skeptical about the reliability of the data.

اظهر المزيد

مقالات ذات صلة

زر الذهاب إلى الأعلى